首页> 外文期刊>Hepatitis Monthly >Prevalence of Hepatitis E Virus Antibodies Among Blood Donors: A Systematic Review and Meta-Analysis
【24h】

Prevalence of Hepatitis E Virus Antibodies Among Blood Donors: A Systematic Review and Meta-Analysis

机译:献血者中戊型肝炎病毒抗体的流行:系统评价和荟萃分析

获取原文
       

摘要

Context: Hepatitis E virus (HEV) is well-known to be transmitted by the fecal-oral route. In addition, several studies in Europe and Asia had reported potential HEV transmission associated with blood transfusion, but this route is still uncertain. Objective: The aim of this study was to estimate the anti-HEV IgG seroprevalence among blood donors around the world using the Bayesian-based methods. Evidence Acquisition: A systematic review was performed using the PubMed/Medline, Scopus, Web of Science and Cochrane Library databases using the terms “prevalence”, “hepatitis E” and “blood donors”. Studies with a timeframe from inception to March 2016, in Roman characters, that had outcomes of interest such as prevalence of IgG antibodies were included. The estimation of anti-HEV IgG (presented as the event rate and 95% confidence intervals, CI) was performed using a Bayesian-based random effect model using the Comprehensive Meta-Analysis software, version 2. Pairwise meta-analyses and chi-square tests were used to assess significant differences between different sexes and ages. Results and Conclusions: Of the retrieved studies, 71 met the inclusion criteria, comprising a total of 113 316 blood donors. The prevalence rate was statistically significant in males and over 40 years old donors (P < 0.05). The overall estimation of the anti-HEV IgG prevalence was 0.058 (CI 95%: 0.049 - 0.068). Subgrouping by region, the estimates were higher for Asia and the Middle East, respectively: 0.113 (CI 95%: 0.040 - 0.278) and 0.112 (CI 95%: 0.081 - 0.152). Europe, Africa, Oceania and America had an estimated prevalence between 0.014and 0.088. A relevant prevalence of anti-HEV IgG among blood donors was found worldwide, especially in Asia and the Middle East and in males and donors over 40 years. This review reinforces the view that HEV parenteral route infection needs to be further investigated and possibly screened for in transfused blood.
机译:背景:众所周知,戊型肝炎病毒(HEV)是通过粪-口途径传播的。此外,欧洲和亚洲的一些研究报告了与输血有关的潜在的戊型肝炎病毒传播,但这种途径仍不确定。目的:本研究的目的是使用基于贝叶斯的方法评估全球献血者中的抗HEV IgG血清阳性率。证据采集:使用PubMed / Medline,Scopus,Web of Science和Cochrane图书馆数据库进行了系统评价,使用了“患病率”,“戊型肝炎”和“献血者”一词。研究包括从开始到2016年3月的罗马字符时间框架,这些研究具有令人感兴趣的结果,例如IgG抗体的流行。使用基于贝叶斯的随机效应模型(使用版本2的综合荟萃分析软件)对抗HEV IgG进行估算(表示为事件发生率和95%置信区间,CI)。成对荟萃分析和卡方测试用于评估不同性别和年龄之间的显着差异。结果与结论:在检索到的研究中,有71个符合纳入标准,包括总共113 316个献血者。男性和40岁以上的捐献者中的患病率具有统计学意义(P <0.05)。抗HEV IgG患病率的总体估计值为0.058(CI 95%:0.049-0.068)。按区域分组,亚洲和中东的估计值分别更高:0.113(CI 95%:0.040-0.278)和0.112(CI 95%:0.081-0.152)。欧洲,非洲,大洋洲和美洲的患病率估计在0.014至0.088之间。在全世界范围内,特别是在亚洲和中东,以及超过40年的男性和献血者中,发现了献血者中抗HEV IgG的相关患病率。这篇评论强化了这样的观点,即需要进一步研究HEV肠胃外途径感染,并可能在输血中进行筛查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号